Riddell, David R.

ApoE Promotes the Proteolytic Degradation of Aβ

Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 876

Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels

Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008) · The Journal of Neuroscience

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 346

The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

Riddell, D. R., Zhou, H., Comery, T. A., Kouranova, E., Lo, C. F., Warwick, H. K., Ring, R. H., Kirksey, Y., Aschmies, S., Xu, J., et al. (2007) · Molecular and Cellular Neuroscience

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 244

Apolipoprotein E Inhibits Platelet Aggregation through the L-Arginine:Nitric Oxide Pathway

Riddell, D. R., Graham, A., & Owen, J. S. (1997) · Journal of Biological Chemistry

Platelet Disorders and TreatmentsNitric Oxide and Endothelin Effects

Cited by 209

Identification and characterization of LRP8 (apoER2) in human blood platelets

Riddell, D. R., Vinogradov, D. V., Stannard, A. K., Chadwick, N., & Owen, J. S. (1999) · Journal of Lipid Research

Platelet Disorders and TreatmentsCholesterol and Lipid Metabolism

Cited by 106